---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-244725"
form_type: "8-K"
ticker: "OSRH"
cik: "0001840425"
company_name: "OSR Holdings, Inc."
filed_at: "2024-10-28T23:59:59+00:00"
generated_at: "2026-05-30T09:48:00.613433+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Bellevue Life Sciences advances $300K loan to OSR Holdings at 3.96% annual interest

## Summary
- Loan of $300,000 to OSR Holdings, target of proposed business combination, evidenced by promissory note.
- Interest rate 3.96% per annum, compound semi-annually; principal and interest due October 25, 2025.
- Funds to be used for working capital and other expenses of OSR Holdings.
- Default provisions include failure to pay within 5 business days of maturity and bankruptcy events.

## SEC filing metadata
- accession: 0001193125-24-244725
- form_type: 8-K
- ticker: OSRH
- cik: 0001840425
- company_name: OSR Holdings, Inc.
- filed_at: 2024-10-28T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840425/000119312524244725/0001193125-24-244725-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840425/000119312524244725/d889585d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-244725
- JSON: https://secwatch.observer/filing/0001193125-24-244725.json
- Plain text: https://secwatch.observer/filing/0001193125-24-244725.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.